Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,373 | Dovepress* | 4,845+ | 858 | 5,703 | |
| PubMed Central* | 528 | 195 | 723 | ||
| Totals | 5,373 | 1,053 | 6,426 | ||
| *Since 22 May 2020 | |||||
View citations on PubMed Central and Google Scholar